Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Antibody-Drug Conjugate SC16LD6.5

Known as: Anti-SC16 ADC SC16LD6.5, SC16LD6.5 
An antibody-drug conjugate (ADC) containing an antibody directed against the scr-like kinase Fyn3 (SC-16), conjugated to the cytotoxic agent D6.5… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
DLL3 is overexpressed in neuroendocrine prostate cancer and is a potential therapeutic target. Lessons from one tumor help with… Expand
2017
2017
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer.
The Notch ligand DLL3 has emerged as a novel therapeutic target expressed in small cell lung cancer (SCLC) and high-grade… Expand
2017
2017
Abstract 3093: Expression of DLL3 in metastatic melanoma, glioblastoma and high-grade extrapulmonary neuroendocrine carcinomas as potential indications for rovalpituzumab tesirine (Rova-T; SC16LD6.5…
Expression of DLL3 was examined in additional tumor types, as it was found to be highly expressed in tumor-initiating cells (TIC… Expand
2016
2016
Safety and efficacy of single-agent rovalpituzumab tesirine (SC16LD6.5), a delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC) in recurrent or refractory small cell lung cancer (SCLC).
LBA8505Background: SCLC remains among the most deadly of malignancies. Rovalpituzumab tesirine is a first-in-class ADC comprised… Expand
2016
2016
Toppling high-grade pulmonary neuroendocrine tumors with a DLL3-targeted trojan horse
  • S. Dylla
  • Molecular & cellular oncology
  • 2016
    • Corpus ID: 41908753
ABSTRACT Delta-like protein 3 (DLL3) is a novel and tractable tumor-initiating cell-associated target for the antibody-drug… Expand
2016
2016
LANL SC16 Green500
Highly Cited
2015
Highly Cited
2015
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo
Targeting DLL3 with an antibody-drug conjugate eliminates tumor-initiating cells in high-grade pulmonary neuroendocrine cancers… Expand
2003
2003
Formation and relaxation of coherency strain in the nickel-base superalloy SC16.
An in situ study of the kinetics of relaxation of the gamma-gamma' lattice mismatch in the single-crystal Ni-base superalloy SC16… Expand
2003
2003
Simulation of solidification and heat treatment of nickel-base superalloy SC16
Thermodynamic equilibrium and Gulliver – Scheil as well as diffusion calculations using the DICTRA program have been made to… Expand
Highly Cited
1995
Highly Cited
1995
First-principles pseudopotential study of the phase stability of the III-V semiconductors GaAs and AlAs.
A first-principles pseudopotential study of the phase stability of the III-V semiconductors GaAs and AlAs is reported. For both… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE